Arbutus Stock Soars 20% After Court Rules Against Moderna In Covid Vaccine Patent Claim

Retrieved on: 2024-04-03 19:58:32

Tags for this article:

Arbutus Biopharma

Abus

Click the tags to see associated articles and topics

Arbutus Stock Soars 20% After Court Rules Against Moderna In Covid Vaccine Patent Claim. View article details on HISWAI: https://www.tradingview.com/news/benzinga:009fa1b43094b:0-arbutus-stock-soars-20-after-court-rules-against-moderna-in-covid-vaccine-patent-claim/

Summary

The article discusses Arbutus Biopharma's successful step in its patent infringement lawsuit against Moderna related to mRNA technology used in COVID vaccines, possibly affecting Moderna's litigation position.

Article found on: www.tradingview.com

View Original Article